Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Image-derived arterial input function for quantitative fluorescence imaging of receptor-drug binding in vivo.

Elliott JT, Samkoe KS, Davis SC, Gunn JR, Paulsen KD, Roberts DW, Pogue BW.

J Biophotonics. 2016 Mar;9(3):282-95. doi: 10.1002/jbio.201500162. Epub 2015 Sep 9.

2.

Rapid Recovery of Vesicular Dopamine Levels in Methamphetamine Users in Early Abstinence.

Boileau I, McCluskey T, Tong J, Furukawa Y, Houle S, Kish SJ.

Neuropsychopharmacology. 2016 Mar;41(4):1179-87. doi: 10.1038/npp.2015.267. Epub 2015 Aug 31.

3.

Salience network and parahippocampal dopamine dysfunction in memory-impaired Parkinson disease.

Christopher L, Duff-Canning S, Koshimori Y, Segura B, Boileau I, Chen R, Lang AE, Houle S, Rusjan P, Strafella AP.

Ann Neurol. 2015 Feb;77(2):269-80. doi: 10.1002/ana.24323. Epub 2014 Dec 30.

4.

Combined insular and striatal dopamine dysfunction are associated with executive deficits in Parkinson's disease with mild cognitive impairment.

Christopher L, Marras C, Duff-Canning S, Koshimori Y, Chen R, Boileau I, Segura B, Monchi O, Lang AE, Rusjan P, Houle S, Strafella AP.

Brain. 2014 Feb;137(Pt 2):565-75. doi: 10.1093/brain/awt337. Epub 2013 Dec 12.

5.

Brain imaging of vesicular monoamine transporter type 2 in healthy aging subjects by 18F-FP-(+)-DTBZ PET.

Lin KJ, Weng YH, Hsieh CJ, Lin WY, Wey SP, Kung MP, Yen TC, Lu CS, Hsiao IT.

PLoS One. 2013 Sep 30;8(9):e75952. doi: 10.1371/journal.pone.0075952. eCollection 2013.

6.

Validation of midbrain positron emission tomography measures for nigrostriatal neurons in macaques.

Brown CA, Karimi MK, Tian L, Flores H, Su Y, Tabbal SD, Loftin SK, Moerlein SM, Perlmutter JS.

Ann Neurol. 2013 Oct;74(4):602-10. doi: 10.1002/ana.23939. Epub 2013 Sep 16.

7.

In vivo evidence for low striatal vesicular monoamine transporter 2 (VMAT2) availability in cocaine abusers.

Narendran R, Lopresti BJ, Martinez D, Mason NS, Himes M, May MA, Daley DC, Price JC, Mathis CA, Frankle WG.

Am J Psychiatry. 2012 Jan;169(1):55-63. doi: 10.1176/appi.ajp.2011.11010126. Epub 2011 Oct 31.

8.

Imaging of beta-cell mass and function.

Ichise M, Harris PE.

J Nucl Med. 2010 Jul;51(7):1001-4. doi: 10.2967/jnumed.109.068999. Epub 2010 Jun 16. Review.

9.

11C-dihydrotetrabenazine PET of the pancreas in subjects with long-standing type 1 diabetes and in healthy controls.

Goland R, Freeby M, Parsey R, Saisho Y, Kumar D, Simpson N, Hirsch J, Prince M, Maffei A, Mann JJ, Butler PC, Van Heertum R, Leibel RL, Ichise M, Harris PE.

J Nucl Med. 2009 Mar;50(3):382-9. doi: 10.2967/jnumed.108.054866. Epub 2009 Feb 17. Erratum in: J Nucl Med. 2009 Oct;50(10):1578.

10.

In vivo imaging of vesicular monoamine transporter 2 in pancreas using an (18)F epoxide derivative of tetrabenazine.

Kung HF, Lieberman BP, Zhuang ZP, Oya S, Kung MP, Choi SR, Poessl K, Blankemeyer E, Hou C, Skovronsky D, Kilbourn M.

Nucl Med Biol. 2008 Nov;35(8):825-37. doi: 10.1016/j.nucmedbio.2008.08.004.

11.

Kinetic analysis of [11C]McN5652: a serotonin transporter radioligand.

Szabo Z, Scheffel U, Mathews WB, Ravert HT, Szabo K, Kraut M, Palmon S, Ricaurte GA, Dannals RF.

J Cereb Blood Flow Metab. 1999 Sep;19(9):967-81.

Supplemental Content

Support Center